189 related articles for article (PubMed ID: 32442222)
1. The intestinal virome in children with cystic fibrosis differs from healthy controls.
Coffey MJ; Low I; Stelzer-Braid S; Wemheuer B; Garg M; Thomas T; Jaffe A; Rawlinson WD; Ooi CY
PLoS One; 2020; 15(5):e0233557. PubMed ID: 32442222
[TBL] [Abstract][Full Text] [Related]
2. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood?
Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY
J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis.
Coffey MJ; Nielsen S; Wemheuer B; Kaakoush NO; Garg M; Needham B; Pickford R; Jaffe A; Thomas T; Ooi CY
Sci Rep; 2019 Dec; 9(1):18593. PubMed ID: 31819107
[TBL] [Abstract][Full Text] [Related]
4. Intestinal inflammation and impact on growth in children with cystic fibrosis.
Dhaliwal J; Leach S; Katz T; Nahidi L; Pang T; Lee JM; Strachan R; Day AS; Jaffe A; Ooi CY
J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):521-6. PubMed ID: 25539196
[TBL] [Abstract][Full Text] [Related]
5. Viral dysbiosis in children with new-onset celiac disease.
El Mouzan M; Assiri A; Al Sarkhy A; Alasmi M; Saeed A; Al-Hussaini A; AlSaleem B; Al Mofarreh M
PLoS One; 2022; 17(1):e0262108. PubMed ID: 35030192
[TBL] [Abstract][Full Text] [Related]
6. Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10years old.
Garg M; Leach ST; Pang T; Needham B; Coffey MJ; Katz T; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY
J Cyst Fibros; 2018 Jan; 17(1):109-113. PubMed ID: 28754328
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children.
Garg M; Leach ST; Coffey MJ; Katz T; Strachan R; Pang T; Needham B; Lui K; Ali F; Day AS; Appleton L; Moeeni V; Jaffe A; Ooi CY
J Cyst Fibros; 2017 Sep; 16(5):631-636. PubMed ID: 28416415
[TBL] [Abstract][Full Text] [Related]
8. Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?
Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A
Dig Dis Sci; 2015 Oct; 60(10):2946-52. PubMed ID: 26271615
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
10. Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.
Bruzzese E; Callegari ML; Raia V; Viscovo S; Scotto R; Ferrari S; Morelli L; Buccigrossi V; Lo Vecchio A; Ruberto E; Guarino A
PLoS One; 2014; 9(2):e87796. PubMed ID: 24586292
[TBL] [Abstract][Full Text] [Related]
11. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
[TBL] [Abstract][Full Text] [Related]
12. Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals.
Willner D; Furlan M; Haynes M; Schmieder R; Angly FE; Silva J; Tammadoni S; Nosrat B; Conrad D; Rohwer F
PLoS One; 2009 Oct; 4(10):e7370. PubMed ID: 19816605
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the Gut Virome in Obesity and Type 2 Diabetes Mellitus.
Yang K; Niu J; Zuo T; Sun Y; Xu Z; Tang W; Liu Q; Zhang J; Ng EKW; Wong SKH; Yeoh YK; Chan PKS; Chan FKL; Miao Y; Ng SC
Gastroenterology; 2021 Oct; 161(4):1257-1269.e13. PubMed ID: 34175280
[TBL] [Abstract][Full Text] [Related]
14. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosis.
Debyser G; Mesuere B; Clement L; Van de Weygaert J; Van Hecke P; Duytschaever G; Aerts M; Dawyndt P; De Boeck K; Vandamme P; Devreese B
J Cyst Fibros; 2016 Mar; 15(2):242-50. PubMed ID: 26330184
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for stool metabolomics in cystic fibrosis?
Kaakoush NO; Pickford R; Jaffe A; Ooi CY
Pediatr Int; 2016 Aug; 58(8):808-11. PubMed ID: 27553892
[TBL] [Abstract][Full Text] [Related]
16. Gut mucosal virome alterations in ulcerative colitis.
Zuo T; Lu XJ; Zhang Y; Cheung CP; Lam S; Zhang F; Tang W; Ching JYL; Zhao R; Chan PKS; Sung JJY; Yu J; Chan FKL; Cao Q; Sheng JQ; Ng SC
Gut; 2019 Jul; 68(7):1169-1179. PubMed ID: 30842211
[TBL] [Abstract][Full Text] [Related]
17. Fecal dysbiosis in infants with cystic fibrosis is associated with early linear growth failure.
Hayden HS; Eng A; Pope CE; Brittnacher MJ; Vo AT; Weiss EJ; Hager KR; Martin BD; Leung DH; Heltshe SL; Borenstein E; Miller SI; Hoffman LR
Nat Med; 2020 Feb; 26(2):215-221. PubMed ID: 31959989
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a Cystic Fibrosis Enteropathy.
Adriaanse MP; van der Sande LJ; van den Neucker AM; Menheere PP; Dompeling E; Buurman WA; Vreugdenhil AC
PLoS One; 2015; 10(10):e0138062. PubMed ID: 26484665
[TBL] [Abstract][Full Text] [Related]
19. Serum Level of D-Lactate in Patients with Cystic Fibrosis: Preliminary Data.
Więcek S; Chudek J; Woś H; Bożentowicz-Wikarek M; Kordys-Darmolinska B; Grzybowska-Chlebowczyk U
Dis Markers; 2018; 2018():5940893. PubMed ID: 30116405
[TBL] [Abstract][Full Text] [Related]
20. Imbalance of the intestinal virome and altered viral-bacterial interactions caused by a conditional deletion of the vitamin D receptor.
Zhang J; Zhang Y; Xia Y; Sun J
Gut Microbes; 2021; 13(1):1957408. PubMed ID: 34375154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
